My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

217.72 -0.91 (-0.42%)

Official Closing Price Updated: 7:00 PM EDT, May 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

Addiction Treatment Market Size, Demand, Growth By 2035 ↗

May 29, 2026

The most recent research report on the "Addiction Treatment Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts

Via Talk Markets

Topics Economy

VYM vs. SCHD: Which U.S. Dividend ETF Is a Better Buy? ↗

May 29, 2026

When choosing dividend ETFs, diversification is a top priority.

Via The Motley Fool

Topics ETFs

2 ETFs That Have Held Up Best During Every Recent Market Pullback ↗

May 29, 2026

These two exchange-traded funds have soundly beaten the markets during recent downturns.

Via The Motley Fool

Topics ETFs Stocks

Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗

May 28, 2026

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

Via MarketBeat

Topics Earnings

5 High-Yield Stocks and ETFs to Buy and Hold for the Next Decade ↗

May 26, 2026

Five high-yield names spanning pharmaceuticals, consumer staples, energy, and ETFs offer income investors compelling yields and durable businesses for a ten-year hold.

Via MarketBeat

Topics ETFs

Prediction: These 2 Obesity Drug Stocks Could Double in 2026 ↗

May 26, 2026

These players are seeing exciting results in clinical trials.

Via The Motley Fool

Chemical Peel Market Size, Industry Share By 2035 ↗

May 25, 2026

The most recent research report on the "Chemical Peel Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts, and

Via Talk Markets

Topics Economy

What's the Better Dividend Stock Today: AbbVie or Pfizer? ↗

May 24, 2026

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.

Via The Motley Fool

Topics Intellectual Property

3 Monster Dividend Stocks to Hold for the Next 10 Years ↗

May 24, 2026

These stocks are built for the long haul. And they pay great dividends.

Via The Motley Fool

Topics Energy Intellectual Property

The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech ↗

May 22, 2026

When investors take a risk-off attitude, stocks with attractive, growing dividends are often their safe-haven option.

Via The Motley Fool

Healthcare Stocks Are on Fire -- Don't Miss These Opportunities ↗

May 22, 2026

The healthcare sector outperformed the rest of the market over the past week.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market ↗

May 22, 2026

This big pharma stock checks off a lot of boxes.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

2 Stocks That Are Much Cheaper Than They Look ↗

May 19, 2026

Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.

Via The Motley Fool

2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts ↗

May 19, 2026

One is a well-known pharmaceutical company; the other is the king of the medical device segment.

Via The Motley Fool

Topics Intellectual Property

2 Reasons to Like ABBV and 1 to Stay Skeptical

May 15, 2026

Over the past six months, AbbVie’s shares (currently trading at $211.15) have posted a disappointing 9.8% loss, well below the S&P 500’s 11.5% gain. This mig...

Via StockStory

Topics Stocks Supply Chain

5 Stocks to Own For the Next 10 Years ↗

May 14, 2026

All High Quality Names

Via The Motley Fool

3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow ↗

May 12, 2026

How does a rising 3.4% dividend and a growing portfolio of drugs sound?

Via The Motley Fool

Topics Intellectual Property

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried? ↗

May 11, 2026

It's not the news that AbbVie needed, given the challenging year it is having.

Via The Motley Fool

2 Cash-Producing Stocks to Research Further and 1 We Find Risky

May 11, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk ↗

May 10, 2026

This mortgage REIT generates income by originating and managing commercial real estate loans across the United States.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress ↗

May 10, 2026

Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends.

Via The Motley Fool

AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting ↗

May 09, 2026

AbbVie (NYSE:ABBV) told shareholders at its annual meeting that 2025 was “another excellent year” for the company, citing record sales, stronger-than-expected revenue and continued investment in its...

Via MarketBeat

Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗

May 06, 2026

They have combined for 118 years of consecutive dividend increases.

Via The Motley Fool

Topics Intellectual Property

Want Reliable Dividend Income in May? These 2 Stocks Deliver ↗

May 06, 2026

These stocks check off multiple boxes for income investors.

Via The Motley Fool

Topics Economy Intellectual Property

5 Must-Read Analyst Questions From AbbVie’s Q1 Earnings Call

May 06, 2026

AbbVie’s first quarter results for 2026 exceeded management’s guidance midpoint and internal expectations, with adjusted earnings per share and revenue comin...

Via StockStory

Topics Earnings

Want to Collect a High Dividend Every Month? Invest in These 3 Stocks ↗

May 05, 2026

By holding these top income stocks in your portfolio, you can have a position in some great companies while also generating cash flow each month.

Via The Motley Fool

Topics Intellectual Property

AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook ↗

May 04, 2026

But is the stock a buy on the dip?

Via The Motley Fool

3 of the Best Dividend Stocks to Buy in May 2026 ↗

May 04, 2026

These stocks offer high yields, attractive valuations, significant upside, and can be terrific investments to buy right now.

Via The Motley Fool

Topics Intellectual Property

The Best Stocks to Buy With $1,000 Right Now ↗

May 03, 2026

The timing is great for scooping up shares of these well-run companies.

Via The Motley Fool

Topics Artificial Intelligence Earnings

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗

May 02, 2026

Via MarketBeat

< Previous 1 2 3 4 5 6 7 8 9

...

90 91 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.